GRFS · Grifols SA · Metrics
Market Cap
$5.00B
Shares
680.58M
Volume · Oct 2
390.35K
Avg daily vol (3M)
604.84K
GRFS metrics
50 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$7.31
Market cap
$5.00B
Price action
20 metricsPrice change (1W)
-0.5%
Price change (30D)
-6.3%
Price change (3M)
+2.1%
Price change (6M)
-11.3%
Price change (YTD)
-21.8%
Price change (1Y)
-27.0%
Trailing year
Price change (5Y)
-50.9%
52-week high
$10.02
52-week low
$7.02
Change from 52-week high
-27.0%
Change from 52-week low
+4.1%
Annualized volatility
31.8%
Annualized volatility (3M)
29.8%
Beta
0.9
RSI (14D)
41.4
Price vs SMA 50
-5.3%
Price vs SMA 200
-10.3%
Avg volume (3M)
604,838
Relative volume
0.7
Average dollar volume
$4.60M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
680.58M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
0.8
reciprocal yield 123.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-07-28
Profitability
9 metricsGross margin
38.0%
Operating margin
16.5%
Trailing 12 months
Net margin
5.3%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+4.3%
Year over year
Net income growth YoY
+156.1%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+156.5%
Shares change YoY
—
Year over year · more shares
Revenue CAGR (3Y)
+7.5%
Revenue CAGR (5Y)
+7.1%
EPS CAGR (3Y)
+29.8%
EPS CAGR (5Y)
-8.1%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-1.2%
Quality
14 metricsReturn on equity
7.6%
Return on assets
2.0%
Debt / equity
—
Current ratio
2.5
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$968.22M
Total assets
$23.13B
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
164
13F filer change QoQ
-24
Institutional ownership
21.0%
Short interest
3 metricsShort interest
0.5%
Latest settlement · 8.8 days to cover
Days to cover
8.8d
Short-squeeze score
50 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—